Calls for a boycott of several prominent brands circulated on social media after two executives questioned the value of Michigan's MED caregiver system. 
Grown In

Growing outside the licensed industry, by caregivers or homegrow hobbyists, can encroach on corporate revenue. Michigan has 30,000+ caregivers serving 250,000+ patients and they remain a source of frustration for some companies with a presence in the state. 

• On May 10, Ryan Ori, an executive at grower Six Labs said in a podcast interview “We’re competing against people who are not only cheating, but putting the public at risk, and these are tax dollars not going into your coffers.”  
• Steve Linder, executive director of the Michigan Cannabis Manufacturers' Association(MCMA), added that caregivers "don't test, don't create jobs and don't pay taxes." (Neither Six Labs nor Linder responded to requests for comment. MCMA's web site also reportedly went dark.)  

While meaningful action action Michigan caretakers seems unlikely, homegrow activists on social media still called for a boycott of brands affiliated with MCMA.

• Their targets include prominent multi-state brands including Kiva Confections, Wana Brands and Sherbinskis which have partnered with MCMA members.
• Kiva and Wana, which have partnerships with MCMA member High Life Farms, declined to comment. High Life didn't respond to a request for comment. 
• In a statement to WeedWeek, Sherbinskis founder Mario Guzman wrote "We stand with caregivers." He didn't reconcile the statement with Sherbinskis' partnership with MCMA member Common Citizen, which didn't respond to requests for comment.
• At least one MSO, Pleasantrees, discontinued its membership in MCMA.

Bottom line: Thus far consumer boycotts haven't been a meaningful force in the cannabis industry. It's not clear if this one has any traction.

Quick Hit

1. Florida's Supreme Court ruled that a challenge to state regulations, which have given rise to a market dominated by a small number of companies, did not have a "substantial likelihood of success." 
   Tampa Bay Times

The MORE Act, a progressive bill that would essentially legalize cannabis federally, was re-introduced by Congressman Jerrold Nadler (D-N.Y.).

• The bill passed the House in December, though Nadler's new version eliminates language, unpopular with liberals, which would have blocked those with past pot convictions from earning federal licenses.
• The bill is unlikely to pass the Senate, which is awaiting an alternative bill from Majority Leader Chuck Schumer (D-N.Y.). Libertarian site Reason asks if Democrats realize they'll need Republican support to pass a legalization bill.

Quick Hit

1. A bill to allow consumption lounges advanced in Nevada.
   Review-Journal

Doings:

• Strong revenue growth among public companies in the last quarter and pot stock prices in the doldrums could catalyze more MSO mergers.
  MJBiz 
• The price per mg of THC is declining, a sign of heightened competition.
  MJBiz
• Data firm BDSA anticipates very strong sales this Memorial Day weekend. It could be that way all summer.
  Green Market Report, Forbes
• Recruiting firm FlowerHire makes the case for hiring veterans.
• Cannabis Wire looks at the licensing and enforcement issues bedeviling the California Cannabis Advisory Committee, which advises regulators.
• Chambers released its list of the top cannabis law firms. Insider put together a list seven firms advising on "megadeals" in the space.
• Connecticut's legislature could vote to legalize REC this week.
  WTNH
• In a win for the industry, a judge tossed out a lawsuit intending to undermine the cultivation boom in Santa Barbara County. Separately, Wine Spectator has a special report on cannabis in wine country.)
  Santa Barbara Independent
• In NorCal, Asian-American growers blame racism for unwanted police attention.
  Sacramento Bee
• Green Market Report spotlights several AAPI industry leaders. Leafly highlights 10 AAPI-owned cannabis brands.
  Sacramento Bee  
• The soaring price of lumber could benefit building materials made from hemp.
  Hempbuild
• The potential benefits of microdosing psychedelics remain in dispute.
  Insider
• Ganjapreneur explains the difference between live resin and live rosin.